Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.375 enrolled

Overview

The purpose of the study is to show the compliance rates of the patients to statin treatment and the reasons of non-compliance.

Study Type

OBSERVATIONAL

Enrollment

375

Conditions

Dyslipidemia

Interventions

Patient ComplianceBEHAVIORAL

Compliance of patients to statin treatment and reasons of compliance or non compliance will be obtained by Patient Reported Outcomes (PROs) every 3 months.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with dyslipidemia and taking or planning to take statin treatment. * Patients living in the same city of the study center. o Patients aged 18 years and over. Exclusion Criteria: * Patients with severe systemic disease * Patients with alcohol and drug addiction and/or mental disease * Patients nursing or pregnant, or planning to get pregnant during the study

Locations (5)

Pfizer Investigational Site

Mecidiyeköy, Istanbul, Turkey (Türkiye)

Pfizer Investigational Site

Bolu, Turkey (Türkiye)

Pfizer Investigational Site

Haseki/Istanbul, Turkey (Türkiye)

Pfizer Investigational Site

Istanbul, Turkey (Türkiye)

Outcomes

Primary Outcomes

Percentage of Participants Who Were Compliant With Statin Treatment

The physician asked participants about their compliance with medication use, which was defined as not skipping or forgetting dosing or not delaying the dosing time at least 80 percent (%) of the days in which the medication was used.

Time frame: Month 12

Secondary Outcomes

Available Lipid Profiles of Compliant and Non-compliant Participants

Available laboratory measurements of participants were recorded in CRFs.

Time frame: Month 12

Number of Participants With Reasons of Compliance to Statin Treatment

Compliance with medication use defined as not skipping or forgeting dosing or not delaying the dosing time at least 80 percent (%) of the days in which the medication was used. Participants were called for a final visit . Compliance with drug dosage was recorded.

Time frame: Month 12

Number of Participants With Reasons of Non-compliance to Statin Treatment

Participants were called for a final visit and reasons for non-compliance were recorded.

Time frame: Month 12

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.